Market Cap 15.39M
Revenue (ttm) 60,000.00
Net Income (ttm) -7.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13,250.00%
Debt to Equity Ratio 0.00
Volume 37,000
Avg Vol 134,448
Day's Range N/A - N/A
Shares Out 10.61M
Stochastic %K 72%
Beta 0.67
Analysts Sell
Price Target $15.50

Company Profile

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It is also developing an allogeneic cells therapy platform...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 226 0120
Fax: 650 631 3731
Address:
320 Soquel Way, Sunnyvale, United States
Raycloser
Raycloser Dec. 11 at 3:00 PM
$BCDA can someone please explain yesterdays insider transaction
1 · Reply
NineLinesCat
NineLinesCat Dec. 11 at 1:00 AM
$BCDA ...here's what's on the horizon, hopefully...
0 · Reply
ghondonn
ghondonn Dec. 8 at 7:27 PM
$BCDA Q4 2025 is coming closer to an end! It's time for Japan information soon! SAKIGAKE SAKIGAK SAKIGAKE
2 · Reply
TheUnmaker
TheUnmaker Dec. 7 at 10:20 PM
$BCDA When is this dilution machine going to run?
1 · Reply
BinarFalcon
BinarFalcon Dec. 6 at 9:44 PM
0 · Reply
BinarFalcon
BinarFalcon Dec. 6 at 9:41 PM
0 · Reply
CHIPPEDNAPPLE
CHIPPEDNAPPLE Dec. 5 at 2:35 PM
$BCDA $55 more to break even! DO SOMETHING, DAMN IT!
0 · Reply
canievas
canievas Dec. 4 at 7:34 PM
$BCDA PATIENTLY WAITING FOR THIS DIAMOND. 🚀🚀🚀🚀🚀 soon
0 · Reply
doyoujetset
doyoujetset Dec. 3 at 2:25 PM
$BCDA “Mr. Slosman currently serves as President, Chief Executive Officer, and Director of InspireMD, a NASDAQ listed medical device company focused on vascular and carotid-artery disease management solutions. In addition to experience as Chief Executive Officer, he has held positions as Chief Operating Officer, and senior commercial-leadership roles at major medical and healthcare companies, including Johnson & Johnson, GE Healthcare, and Baxter International Inc., helping drive commercialization and market development efforts. His background includes significant accomplishments in both public and private growth companies with expertise in regulatory pathways and approvals, strategic partnerships, product development, and operational and commercial growth in global medical technology markets.” https://www.biocardia.com/investors/press-releases/id/1037?pressReleaseId=248
0 · Reply
chris_stocks
chris_stocks Dec. 2 at 12:01 AM
$BCDA So irritating that this keeps dropping. I had hoped it'd hold steady in the 1.40s at least, but now we're back in the 1.30s
1 · Reply
Latest News on BCDA
BioCardia, Inc. (BCDA) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 12:11 AM EST - 4 weeks ago

BioCardia, Inc. (BCDA) Q3 2025 Earnings Call Transcript


BioCardia Regains Compliance with Nasdaq Listing Requirements

Oct 2, 2025, 8:00 AM EDT - 2 months ago

BioCardia Regains Compliance with Nasdaq Listing Requirements


BioCardia Announces Pricing of Up To $12 Million Public Offering

Sep 18, 2025, 9:15 AM EDT - 3 months ago

BioCardia Announces Pricing of Up To $12 Million Public Offering


BioCardia, Inc. (BCDA) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 8:37 PM EDT - 4 months ago

BioCardia, Inc. (BCDA) Q2 2025 Earnings Call Transcript


BioCardia, Inc. (BCDA) Q1 2025 Earnings Call Transcript

May 14, 2025, 7:40 PM EDT - 7 months ago

BioCardia, Inc. (BCDA) Q1 2025 Earnings Call Transcript


BioCardia, Inc. (BCDA) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 11:30 PM EDT - 9 months ago

BioCardia, Inc. (BCDA) Q4 2024 Earnings Call Transcript


BioCardia Reports 2024 Business Highlights and Financial Results

Mar 26, 2025, 4:30 PM EDT - 9 months ago

BioCardia Reports 2024 Business Highlights and Financial Results


BioCardia, Inc. (BCDA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 7:49 PM EST - 1 year ago

BioCardia, Inc. (BCDA) Q3 2024 Earnings Call Transcript


BioCardia, Inc. (BCDA) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 7:53 PM EDT - 1 year ago

BioCardia, Inc. (BCDA) Q2 2024 Earnings Call Transcript


BioCardia Announces Reverse Stock Split

May 21, 2024, 5:00 PM EDT - 1 year ago

BioCardia Announces Reverse Stock Split


BioCardia, Inc. (BCDA) Q1 2024 Earnings Call Transcript

May 14, 2024, 11:00 PM EDT - 1 year ago

BioCardia, Inc. (BCDA) Q1 2024 Earnings Call Transcript


BioCardia, Inc. (BCDA) Q4 2023 Earnings Call Transcript

Mar 27, 2024, 8:00 PM EDT - 1 year ago

BioCardia, Inc. (BCDA) Q4 2023 Earnings Call Transcript


Raycloser
Raycloser Dec. 11 at 3:00 PM
$BCDA can someone please explain yesterdays insider transaction
1 · Reply
NineLinesCat
NineLinesCat Dec. 11 at 1:00 AM
$BCDA ...here's what's on the horizon, hopefully...
0 · Reply
ghondonn
ghondonn Dec. 8 at 7:27 PM
$BCDA Q4 2025 is coming closer to an end! It's time for Japan information soon! SAKIGAKE SAKIGAK SAKIGAKE
2 · Reply
TheUnmaker
TheUnmaker Dec. 7 at 10:20 PM
$BCDA When is this dilution machine going to run?
1 · Reply
BinarFalcon
BinarFalcon Dec. 6 at 9:44 PM
0 · Reply
BinarFalcon
BinarFalcon Dec. 6 at 9:41 PM
0 · Reply
CHIPPEDNAPPLE
CHIPPEDNAPPLE Dec. 5 at 2:35 PM
$BCDA $55 more to break even! DO SOMETHING, DAMN IT!
0 · Reply
canievas
canievas Dec. 4 at 7:34 PM
$BCDA PATIENTLY WAITING FOR THIS DIAMOND. 🚀🚀🚀🚀🚀 soon
0 · Reply
doyoujetset
doyoujetset Dec. 3 at 2:25 PM
$BCDA “Mr. Slosman currently serves as President, Chief Executive Officer, and Director of InspireMD, a NASDAQ listed medical device company focused on vascular and carotid-artery disease management solutions. In addition to experience as Chief Executive Officer, he has held positions as Chief Operating Officer, and senior commercial-leadership roles at major medical and healthcare companies, including Johnson & Johnson, GE Healthcare, and Baxter International Inc., helping drive commercialization and market development efforts. His background includes significant accomplishments in both public and private growth companies with expertise in regulatory pathways and approvals, strategic partnerships, product development, and operational and commercial growth in global medical technology markets.” https://www.biocardia.com/investors/press-releases/id/1037?pressReleaseId=248
0 · Reply
chris_stocks
chris_stocks Dec. 2 at 12:01 AM
$BCDA So irritating that this keeps dropping. I had hoped it'd hold steady in the 1.40s at least, but now we're back in the 1.30s
1 · Reply
NineLinesCat
NineLinesCat Dec. 1 at 11:33 PM
$BCDA ...Yikes! Still have faith. Good things coming...
0 · Reply
NineLinesCat
NineLinesCat Nov. 27 at 1:35 AM
$BCDA ...BCDA traders, Happy Thanksgiving...
0 · Reply
chris_stocks
chris_stocks Nov. 25 at 6:15 PM
$BCDA Probably won't see much in the way of movement for at least a few weeks.
2 · Reply
doyoujetset
doyoujetset Nov. 24 at 4:05 PM
$BCDA “Farhan’s expertise in product quality management and supporting regulatory submissions across a number of product categories will be invaluable for our team.” commented Peter Altman, PhD, CEO of BioCardia. “We are delighted to welcome Farhan. His past proven leadership and extensive relevant experience have potential to accelerate our ability to commercialize our investigational products.” https://www.biocardia.com/investors/press-releases/id/1037?pressReleaseId=246
0 · Reply
Jusme
Jusme Nov. 21 at 4:17 PM
$BCDA BioCardia CEO Peter Altman, Ph.D. “These next two quarters promise to be truly transformative for our business because of these and other activities underway.” 🧐
3 · Reply
doyoujetset
doyoujetset Nov. 18 at 6:19 PM
$BCDA held volume support from last offering. Flushed into ER. Ready to move up with upcoming fundamentals with Japan and FDA updates.
0 · Reply
NineLinesCat
NineLinesCat Nov. 15 at 5:19 AM
$BCDA ...yeah, was supposed to go here...
1 · Reply
chris_stocks
chris_stocks Nov. 13 at 12:44 AM
$BCDA Here are the 10-Q and the 8-K: https://www.sec.gov/ix?doc=/Archives/edgar/data/0000925741/000143774925034442/bcda20251112_8k.htm https://www.sec.gov/ix?doc=/Archives/edgar/data/0000925741/000143774925034437/bcda20250930_10q.htm Here's also something from StockTitan: https://www.stocktitan.net/news/BCDA/bio-cardia-reports-third-quarter-2025-business-highlights-and-7rxhyufcj2vo.html
1 · Reply
Tom678
Tom678 Nov. 12 at 9:51 PM
$BCDA agree
0 · Reply
Logan12071
Logan12071 Nov. 12 at 9:43 PM
$BCDA great earnings
1 · Reply
Lstreak
Lstreak Nov. 12 at 5:28 PM
$BCDA Sad to see this so low again. Hoping for a good earnings report and positive guidance.
0 · Reply
chris_stocks
chris_stocks Nov. 12 at 7:27 AM
$BCDA Anyone have an idea of how long it'll take before phase 3 is completed?
1 · Reply